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Summary.-The possibility that anticoagulation with warfarin might inhibit the
development of spontaneous metastases from intestinal carcinomas induced by
azoxymethane (AOM) was tested in Sprague-Dawley rats with and without 60%
distal small-bowel resection (DSBR). Warfarin (0-5 mg/l) was added to the drinking
water from 1 week or 12 weeks postoperatively, and thromboplastin times were
measured thereafter. AOM was given by 12 weekly s.c. injections (10 mg/kg/week),
starting 1 week after DSBR. Besides increasing the sensitivity of rats to warfarin,
DSBR itself caused partial anticoagulation, probably because of vitamin K mal-
absorption: at 30 weeks faecal fat was 59-93%O higher, while serum B12 was 4000
lower (>005 P >0.005). Adaptive growth of the jejunum and caecum after DSBR
was manifested by22-760/ increases in segmental weight and surface area (P<0.001).
DSBR produced a 4-fold increase in duodenojejunal tumours at 15-25 weeks (P=
0 025) and a 76% increase in colorectal tumours at 25-35 weeks (P<0-005). Eight of
20 control rats dying after 15 weeks had lymphatic metastases, compared with 0 of
15 rats with DSBR plus warfarin from week 1 (P=0-005). The overall prevalence of
metastases was reduced by both DSBR and warfarin, when assessed independently.
Intestinal carcinogenesis induced by AOM is enhanced by the adaptive response to
DSBR, but anticoagulation inhibits spontaneous metastases in this model.
THE RELATIONSHIP between malignant
disease and blood coagulability is recog-
nized but not completely understood.
Migratory thrombophlebitis is a presenting
feature of certain visceral carcinomas, and
may be one manifestation of a "hyper-
coagulable state" (Amundsen et al., 1963).
By contrast, patients on long-term anti-
coagulant therapy may have a lower
incidence of metastatic cancer (Michaels,
1964). Certain tumours contain thrombin
or other clotting factors which cause local
deposition offibrin, and could thus enable
malignant cells to invade adjacent tissues
or secure a footing in organs distant to the
primary growth (Laki & Yancy, 1968;
O'Meara, 1958). Indeed, since most em-
bolic tumour cells are destroyed (Engell,
1959) adherence to the capillary endo-
thelium and local thrombus formation
may be crucial to the successful establish-
ment of micrometastases (Wood, 1958).
Various anticoagulants can inhibit the
development ofhaematogenous metastases
after injection or implantation of experi-
mental tumour cells. Heparin, warfarin
and fibrinolysin generally protect against
lung deposits after i.v. injection of cells
(Agostino & Cliffton, 1962; Brown, 1973;
Grossi et al., 1960; Poggi et al., 1978) and
against liver deposits after intraportal
injection (Fisher & Fisher, 1961). In less
artificial models, involving transplantation
of tumours to a subcutaneous or intra-
muscular site, both heparin and coumarin
derivatives can inhibit pulmonary meta-
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stases (Brown, 1973; Hilgard et al., 1977;
Hoover et al., 1976; Ryan et al., 1968).
The present study was devised to deter-
mine whether chronic anticoagulation
with warfarin in rats might prevent spon-
taneous metastasis from intestinal carcin-
omas induced by azoxymethane. This
model was considered to be even closer to
the clinical situation than the experiments
with tumour implants: azoxymethane-
induced neoplasms resemble human colo-
rectal cancers in gross and microscopic
appearance, and they develop and spread
in similar ways (Ward, 1974; Williamson
et al., 1978b, 1979b). In addition, we have
further investigated the promotion of
colorectal carcinogenesis by partial enter-
ectomy (Oscarson et al., 1979; Williamson
et al., 1.978b). The data confirm increased
tumour yields in adapted gut on either
side of an extensive distal small-bowel
resection. This operation itself ultimately
causes partial anticoagulation.
MATERIALS AND METHODS
Male Sprague-Dawley rats (n = 188) weigh-
ing 304+18 g (s.d.) were randomized to 8
groups. Four groups had no operation,, hile
4 had 60O/ distal small-bowel resection
(DSBR). Unoperated groups received either
azoxymethane (AOM) alone, vehicle+war-
farin throughout, AOM+warfarin through-
out. or AOM +warfarin from 12 weeks. Rats
with DSBR received either AOM alone,
vehicle alone, AOM+warfarin throughout, or
AOM+warfarin from 12 weeks. This design
included controls for the individual effects
of AOM, -warfarin and DSBR.
DSBR was carried out under light ether
anaesthesia. The small bowel was delivered
andmeasuredfrom theduodenojejunal flexure
(ligament of Treitz) to the ileocaecal valve,
and the distal 60% (55-60 cm) of combined
jejunum and ileum was excised. Intestinal
continuity was restored by direct end-to-end
anastomosis just proximal to the ileocaecal
valve, using one layer of continuous 6/0 silk
sutures.
Azoxymethane in aqueous dilution was
administered by 12 weekly s.c. injections
(10 mg/kg/week), starting 7 days after opera-
tion or, in unoperated rats, 7 days after the
start of the experiment. Dilute solutions of
carcinogen were stored at - 20'C until
required. Rats with vehicle received a similar
course ofinjections ofsterile water.
Warfarin sodium was administered in the
drinking water at a dose of 05 mg/l, starting
either 7 days after operation or the start of
the experiment (war/arin throuqhout), or at
12 weeks, i.e. after the last AOM injection
(warfarin from 12 weeks). Representative
animals from different groups were used for
measurements of daily water intake. The
dose of warfarin was chosen after a pilot
study had shown that doses of 1-3 mg/I
produced a high incidence of fatal haemor-
rhage within 1 month of starting anti-
coagulation; bleeding occurred to a similar
extent in rats with or without DSBR.
Anticoagulation was monitored by measur-
ing thromboplastin time every 2-4 weeks in
3-6 rats per group. Thrombotest reagent
(Nyegaard and Co., Oslo, Norway) was in-
cubated in a water bath at 37°C with blood
samples (0.05 ml) obtained from the caudal
vein. Using this test, normal coagulation
times are about 40 s in man and 46-54 s in
the mouse (Hilgard et al., 1977; Loeliger et al.,
1970). Thrombotest coagulation activity is
expressed as a percentage of normal, using a
correlation curve prepared for each batch of
reagent by serial dilutions of a reference
human plasma. Therapeutic anticoagulation
in man requires maintenance ofthe Thrombo-
test between 5 and 1000, and similar values
can safely be achieved in mice (Hilgard et al.,
1977). In rats, however, increasing the dose
of warfarin sufficiently to obtain equivalent
levels of anticoagulation during the early
weeks of the experiment caused an unaccept-
able incidence of fatal haemorrhage. Only
partial anticoagulation (20-50% activity)
obtained in most animals by a dose of 0-5
mg/l of warfarin, seemed to be compatible
with prolonged survival.
Rats were weighed weekly and observed
for evidence either of bleeding or ofintestinal
cancer, suggested by weight loss, abdominal
distension or rectal bleeding (haematochezia).
Rats were killed when moribund or at the
end of 35 weeks, and a thorough necropsy
was made. The entire intestinal tract was
scrutinized for tumours, and the rest of the
body for metastatic deposits. Specimens were
stored in 10% formalin and subsequently
embedded in paraffin wax. Sections 5 Mtm
thick were stained with haematoxylin and
eosin. Because of the large number of histo-
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logical specimens (- 600) only one section was
prepared from each tumour or metastasis,
unless this failed to confirm the presence of
neoplasia, in which case further sections were
obtained. Neoplasms were classified as non-
invasive or invasive, according to the presence
or absence of carcinoma in the base of the
stalk (pedunculated lesions) or deep to the
muscularis mnucosae (sessile lesions). Non-
invasive tumours included focal atypias,
adenomatous polyps and carcinoma in situ.
The commonest type of invasive tumour was
a papillary or tubular adenocarcinoma ("in-
testinal" type) but some lesions showed a
diffuse (mucinous) pattern with signet-ring
cells, and in others there was a combination of
diffuse and "intestinal" patterns.
To determine the presence of post-resec-
tional adaptation, rats receiving vehicle were
killed at 30 weeks by the following method.
Under general anaesthesia laparotomy was
performed and 5-7 ml of blood were obtained
by direct aortic puncture for spectrophoto-
metric estimation of haemoglobin and for
riadioassay of vitamin B12 (Green et a., 1974).
Thereafter 10-20 ml of 10% formalin was
rapidly injected into the aorta to obtain
immediate fixation of the gut and thus pro-
vide reproducible measurements of intestinal
length (Nygaard, 1967). The ligament of
Treitz was marked with a silk suture. The
entire intestinal tract was then excised by
transection immediately proximal to the
pylorus and the anal canal, and the specimen
was immersed in 100/' formalin for 3 days.
The mesentery and all other extraneous fat
were then meticulously excised and the
lengths ofthe duodenum (pylorus to ligament
of Treitz), combined jejunum and ileum, and
colon (minus caecum) were measured by
gentle stretching against a ruler. These seg-
ments were opened, cleaned, blotted dry and
weighed. The caecum wasopenedandweighed,
and its surface area was estimated by pinning
it flat to a sheet ofpaper (ofknown weight per
surface area) then trimming and weighing the
paper.
Representative animals mith and -w-ithout
DSBR were used for estimations of faecal fat
23-25 weeks after the start ofthe experiment.
Rats were isolated in individual cages with
precautions to minimize coprophagia. Animals
Nvere allowed to adapt to the new environment
for 2 days; faeces were then collected daily
for 3 days, weighed, pooled and frozen. Later,
specimens were thawed and homogenized.
After saponification in hot alcoholic KOH.
lipids wvere extracted in petroleum ether
(60-80°C b.p.) and were quantitated by titra-
tion against tetramethyl ammonium hydrox-
ide. using ethanolic thymol blue as an indica-
tor and stearic acid as a standard.
Statistical significance wvas assessed by
Student's t test, or by Fisher's exact proba-
bility test or the correlation coefficient as
indicated.
RESULTS
Survival and weight gain
Seven of 107 rats with DSBR (6.5%)
died shortly after operation, either from
anastomotic leakage or from chronic
peritonitis. A further 33 rats with DSBR
and 26 without operation died before the
15th week from warfarin overdose. Com-
mon sites ofhaemorrhage included the eye,
the ear canal, the gastrointestinal tract,
the bladder and the retroperitoneal tissues.
A total of 122 rats (65%o) survived for 15
weeks, at which time the first tumour was
found.
Weight gains in all groups were broadly
comparable. Body weight rose steadily to
reach a plateau after about 20 weeks in
unoperated rats, but showed a slight
tendency to fall in the last few weeks as
tumours developed. DSBR caused an
initial 1000 reduction in body weight that
was recovered at 7- 0 days, though mean
values generally remained a little lower
than those in unoperated animals for 25-30
weeks. Neither warfarin nor AOM pro-
duced any consistent change in weight.
Anticoagulation
In unoperated rats without warfarin,
coagulation activity remained between 90
and 100% of normal throughout the ex-
periment (Fig. 1). Within a week of start-
ing warfarin, mean values dropped below
20% in rats with and without operation.
Since the individual animals with the
lowest values usually died ofhaemorrhage,
the mean percentage activity in groups
receiving warfarin subsequently increased
and reached a plateau at 30-60% of
normal.
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Malahsorption
Six months after operation, rats with
DSBR excreted 59-93% more fat in the
stool than unoperated controls (Table 1).
AOM did not affect faecal fat content.
When killed at 30 weeks, rats with DSBR
(and vehicle) had similar haemoglobin
levels (I4-21 + 1-34 g/dl: mean+s.d.) to
unoperated controls (14-56 + 1-34 g/dl),
and examination of the blood film showed
no abnormalities. However, serum B12was
40% lower after DSBR (560 + 59 v8
926 + 234 ng/l: P <0-05).
During the second half of the study it
became apparent that rats with DSBR
were bleeding more readily than their un-
operated counterparts, though from I
week after operation fluid intakes had not
differed between these groups. Cxastro-
intestinal haemorrhage became particu-
larly frequent as intestinal tumours de-
veloped and precipitated death in rats
with DSBR, even in the absence of war-
farin. Thrombotest percentages obtained
20-30 weeks after DSBR alone were only
30-50%, whether rats received AOM or
vehicle. Moreover, the same dose of war-
faringenerallyproduced lowerpercentages
in rats with DSBR than in rats without
TABLE I.-lVeight andfat content offaece8 23-25 week8 after di8tal 8mall bowel re8eCtion
(DSBR) (mean8 +8.d.). In each group, 5-6 rat8 were u8edfor e8timation8
Body
weiglit
(g)
625
Fat content of faeces
(MM/g X 10-2)
33-6 + 1-9
P<0-001
Faeeal weight
(g/day)
7-99 + 0-87
NS
Faecal fat output,
(mm/day)
2-68 + 0-33
P < 0-005
Vehicle+,,A,arfarin
Velilcle + DSBR
Azoxymethane alone
628
635
10-02 + 2-02
8-85 + 1-84
1
5-17 + 1-11
2-99 + 0-50
51.5 + 2-7
34-0 + 2-2
p < 0-01 NS P < 0-002
Azoxymetliane + DSBR 581 10- 18 + 2-46' 4-76 + 1-3 I' 46-7 + 7-1ANTICOAGULATION AND INTESTINAL CANCER
TABLE 11. Length and weight ofintestine afterfixation informnalin (mealns + s.d.)
Segmental
weight
(g/Cm (g/cm2
Wreiglht Lenigtlh Sturface area for caecum)
(g) (cm) (Cm2) x 10-2)
Duodeliilln Control 1-01 + 0 05 111 + 1-1 9-17 + 1-02
DSBR 1-07+0-15 10-2+ 1-4 10-64+ 1-57
Jejunum an(1 ileum Control 7-87 + 0-76 119-4 + 72 6-59 + 0 40
D)SBR 5-10+0-54 48-0+6-5 10-71+1.18***
Caecum Control 1-11+0-17 25 t+3 9 4-44+0-76
1)SBR 2.01 +0-27*** :379+8.1** 540+0-84***
Colon Control 1-96 + 0 25 21.3 + 1 2* 9-21 + 0-91
DSBR 1-99+0-28 18-8+ 13 10-60+1.09*
Valuies were obtained from 5 contiol rats (body wt 640-6 + 49-7 g) and from 9 rats witll distal small-bowel
resection (DSBR) (body w,vt 620-2 + 77-1 g).
Significance: * P< 005; ** P< 0005; *** P< 0-001.
Intestinal adaptation
In the absence of obvious intestinal ob-
structionorhistologicalevidenceofoedema,
changes in the wetweight ofintestinal seg-
ments probably reflected alterations in cell
mass. Compensatory growth following
DSBR was confined to the bowel immedi-
ately adjacent to the resected ileum (Table
II). Thelength oftheresidualjejunum after
60% DSBR was still 400o ofthe combined
jejunoileal length in unoperated controls,
but its total wet weight was 65% of con-
trol values; the weight per cm ofproximal
small bowel was thus 76% higher after
DSBR. In the caecum 30 weeks after
DSBR, total weight, surface area and
segmental weight were increased by 22-
51%. Although the segmental weight of
the colon was slightly greater after opera-
tion, its length was decreased and its
overall wet weight was thus unchanged.
No adaptive changes were detected in the
duodenum after DSBR.
Tumour yields
In rats with and without IDSBR, no
tumours were found in either the small
bowel or the large bowel within 15 weeks
of the first injection of AOM. Thereafter
virtually every rat had at least one in-
testinal tumour, and in those dying pre-
maturely there was usually evidence of
intestinal bleeding. In unoperated animals
the yields of both enteric and colorectal
tumours increased progressively with age,
and a similar correlation was seen in the
large bowel after DSBR (Fig. 2). Like-
wise, auditory-canal tumours became in-
creasingly common with time, irrespective
of operation or anticoagulation. In the
small bowel after DSBR, however, there
was no correlation betweenageandtumour
incidence. Tumours developed earlier in
the duodenum and jejunum after ileal
resection: DSBR increased the yield of
residual small-bowel tumours per rat from
0 30 to 1P22 (P=0.025) in animals dying
between 15 and 25 weeks. Operation did
not affect the number of tumours arising
in the large bowel before the 25th week, in
the small bowel thereafter, or in the ear
canal at any time (Fig. 3).
In rats without warfarin, dying 25-35
weeks after starting AOM, DSBR in-
creased the yield of colorectal tumours by
76% (P < 0005; Fig. 3). Treatment with
warfarin prevented the promotion of
distal neoplasia by DSBR. In operated
rats anticoagulated from 12 weeks, tumour
yields at all sites were nearly halved, prob-
ably because these animals died from
bleeding at an earlier time than their un-
operated counterparts (Figs 2 and 3).
Of 120 small-bowel tumours, 116 arose
within the duodenum or jejunum and 4
within the upper ileum. The 443 large-
bowel tumours were concentrated in the
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FIG. 2.-Number of tumours per rat in the small bowel and large bowel of animals with and without
distal small-bowel resection (DSBR). Each circle represents one animal. In each graph regression
lines have been calculated using pooled data from all animals, irrespective oftreatment. 0, azoxy-
methane (AOM) alone; 0, AOM+warfarin throughout; 0, AOM +warfarin from 12 weAs.
transverse anddescending colon; no caecal
tumours were seen and there was relative
sparing of the rectum. Tumour distribu-
tion was not affected by DSBR or by
warfarin. Outside the gut tumours were
restricted to the ear canal.
Tumourhistology T NUMBER OF 10-
TUMOORS 9- PER RAT
8-
7-
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1
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No
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LARGE BOWEL
Most small-bowel tumours were invasive
adenocareinomas, the proportion rising
from 67% at 15-25 weeks to 88% at 25-35
weeks. By contrast, only 41% of large-
bowel tumours showed evidence of in-
vasion (P <0-001). Nevertheless, invasive
cancers were twice as common in the large
bowel as in the smallbowel, because ofthe
overall preponderance of tumours in this
region ofthe intestinal tract. At both sites
most carcinomas were of "intestinal"
NO WARFARIN WARFARIN type, but about a quarter displayed a WARFARIN FROM 12 WK.' THROUGHOUT
mucinous pattern in part or the whole of
.........INO OPERATION OSBR the lesion. Operation did not affect
tumour histology, except that a greater
.beroftumours per rat inanimals proportion of non-invasive neoplasms in
,ithout distal small-bowel resec- the small bowel reflected earlier tumour R) and dying at 25-35 weeks
-1.).
* P < 0-05; * * P < 0-005. development at this site after DSBR.
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TABLE III.-Number and distribution ofmetcastcases in rats dying 15-25 weeks and 25-35
after the start of the experiment. Control animals had no operation
No. rats
with
15-25 wk
No warfarin Control
DSBR
Warfarin from Wk 12 Control
DSBR
Warfarin throughout Control
DSBR
25-35 wk
No warfarin Control
DSBR
Warfarin from Wk 12 Control
DSBR
Warfarin throughout Control
DSBR
meta- Local Regional
n stases lymphatic lymphatic
3
12
5
10
2
10
17
10
13
9
10 1*
5 0
Peri- Intra-
toneal thoracic
1 1 1 -
1 1 - 1
5
1
4
1
1
0
1
2
0
0
8
1*
2
O**
8
1
2
1 1 1
Significance vs controls with no warfarin (Fisher's exact probability test): * P < 0-05; ** P < 0-02.
Metastases
Of 42 rats dying before the 25th week,
only 4 had proven metastases; in subse-
quent weeks 12/64 animals had secondary
deposits (Table III). Cancers metastasized
most frequently to epicolic, mesenteric
and para-aortic lymph nodes and occasion-
ally, via the thoracic duct, to mediastinal
nodes. Extensive lymphatic metastases
were sometimes accompanied by trans-
coelomic spread, leading to multiple
peritoneal seedlings and malignant ascites.
The numbers ofmetastases in rats dying
before and after 25 weeks are shown in
Table III. After 25 weeks, nearly half the
TABLE IV.-Overall number of rats with
metastases
No. rats
Total with
Controls (no operation,
no warfarin)
Warfarin from Wk 12
Warfarin throughout
Warfarin total
DSBR alone
DSBR +warfarin
from Wk 12
DSBR +warfarin
throughout
Significant differences
probability test.
animals without DSBR or warfarin had
lymphatic secondaries, and about a quar-
ter had omental and peritoneal deposits.
These figures were substantially lower,
both in rats with DSBR alone and in rats
treated with warfarin throughout. Never-
theless, among unoperated animals, one
rat from each warfarin-treated group
developed carcinomatosis peritonei after
25 weeks. There were no metastases at all
in rats receiving DSBR combined with
warfarin, either from the start or from 12
weeks. Table IV confirms the individual
protective effects of DSBR and warfarin
against metastasis; warfarin appeared to
be slightly more effective when given
throughout the experiment.
DISCUSSION
no. meta- Pvs Chronic warfarin anticoagulation re-
rats stases controls duces spontaneous metastases from in-
20 8 testinal tumours induced by AOM in rats.
18 3 (>0 10) The unexpected discovery that 60% distal
12 1 (0°06) small-bowel resection itself eventually
22 2 0-02 caused partial anticoagulation led to a
range of different thromboplastin times 19 2 0 04 among the various groups of animals,
15 o 0005 which correlated roughly with the degree
assessed by Fisher's exact of metastatic inhibition. The anticoagu-
lant effect of DSBR presumably results
91R. C. N. WILLIAMSON, P. J. LYNDON AND A. J. C. TUDWAY
fromi progressive depletion of fat-soluble
vitamin K; in support ofthis presumption,
haemorrhage from vitamin K deficiency
has been reported in patients with ileal
resection (Compston & Creamer, 1977).
Our results confirm a persistent increase
in faecal fat excretion 6 months after 600,
distal enteric loss, with an associated re-
duction in serum levels of vitamin B12.
Warfarin alone decreased but did not
abolish the incidence ofmetastases. Delay-
ing the start of warfarin therapy until 3
weeks before the first macroscopic tumour
was encountered still produced a trend
towards fewer metastases. In combination
with the anticoagulant effect of distal
enterectomy, warfarin completely pre-
vented secondary spread in surviving
animals, when given throughout the
experiment.
The tumour model used in the present
experiment differs in at least 2 respects
from those used by most other workers
reporting metastatic inhibition by anti-
coagulants. Firstly, in the context of the
life span of the rat, the time scale for the
development and spread of AOM-induced
intestinal neoplasms is closer to human
colorectal cancer than models involving
injection or implantation of malignant
cells. Secondly, these intestinal cancers
disseminate by lymphatic (and trans-
coelomic) routes rather than by the blood-
stream, as seen with transplanted sarcoma
or direct i.v. injection of cancer cells.
Suppression oflymphatic metastases by
warfarin is less readily explained on a
simple basis of anticoagulation, yet the
results suggest an approximate correlation
between antimetastatic effect and coagu-
lation activity. Although warfarin may
exert a cytostatic effect on tumour cells
in vitro and can selectively inhibit their
motility in vivo (Brown, 1973; Thornes et
al., 1968), these properties may be less
important than its direct effect on coagul-
ability of the blood. Thus metastatic
inhibition can be reversed by vitamin K
(Brown, 1973) and dietary-induced de-
ficiency of vitamin K is as effective as
coumarin treatment in preventing secon-
dary spread (Hilgard, 1977). Anticoagula-
tion might prevent lymphatic spread by
stopping fibrin deposition, which would
otherwise facilitate local invasion by
tumour cells (O'Meara, 1958; Wood, 1958).
Unlike some investigators (Hilgard et al.,
1977; Hoover et al., 1976), we have shown
no direct inhibitory effect of warfarin on
primary tumour growth, nor have we
demonstrated a critical level of anti-
coagulation for the prevention of meta-
stases (Hilgard et al., 1977). There is no
evidence that anticoagulation alters only
the distribution of metastases and not
their total number, as obtained with
heparin after i.v. injection ofsarcoma cells
in mice (Hagmar & Norrby, 1970). Our
preliminary report that neither heparin
nor warfarin protect against lung deposits
after i.v. injection of mammary carcinoma
cells in A-strain mice (Williamson et al.,
1978c) seems inconsistent with the present
results. However, the failure of anti-
coagulants to inhibit seedling tttmours in
the first capillary bed exposed to a massive
bolus injection of cells (0.5-1-0 x 106)
scarcely detracts from their ability to
decrease spontaneous metastases, as
shown in the present study.
Besides increasing the incidence of
colonic tumours after the 25th week, distal
enterectomy accelerated the development
of tumours in the upper small bowel. Like
the adaptive response itself (Williamson,
1978) iincreased tumour yields thus occur
on either side of the resected segment of
gut. This enhancement ofintestinal carcin-
ogenesis by compensatory hyperplasia
is entirely consistent with previous re-
ports showing promotion of neoplasia in
the adapted gut by jejunal resection, ileal
resection, pancreatobiliary diversion or
subtotal enterectomy (Oscarson et al.,
1979; Williamson et al., 1978b, 1979b,
1980). AOM itself causes mucosal hyper-
plasia before the appearance of macro-
scopic tumours (XVilliamsoni et al., 1978b)
and partial intestinal resection may simply
increase the number of epithelial cells
available for malignant transformation.
Analogouis mechanisms couild explain the
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development of metachronous colorectal
cancers in man or thepromotion ofhepatic
carcinogenesis by partial hepatectomy in
rats (Pound & McGuire, 1978). Further-
more, the development of experimental
large-bowel tumours is accelerated by
bacterially induced hyperplasia (Barthold
& Jonas, 1977) reduced by the atrophy of
colonic diversion (Campbell et al., 1975)
and enhanced by restoration of the faecal
stream (Terpstra et al., 1979).
The absence of any tumours at the ileal
anastomosis contrasts with the relatively
high incidence of cancers inducedby AOM
at suture lines in the duodenum, jejunum
or colon (Williamson et al, 1978b, 1979b,
1980). The resistance of the ileum to
experimental careinogenesis, even with
the stimulus of adaptive hyperplasia,
accords with the rarity of ileal carcinoma
in man (Williamson et al., 1978b, 1979a,b).
Although wet weight is a relatively
crude index of intestinal adaptation, the
results suggest that loss ofthe distal small
bowel is eventually compensated by
hyperplasia of the jejunum and caecum.
The initial increase in colonic cell pro-
liferation that follows ileal resection
(Nundy et al., 1977) and probably ex-
plains the enhanced careinogenesis (Oscar-
son et al., 1979) may become superfluous
when adaptation by the adjacent bowel is
fully established. Similarly, transient
colonic hyperplasia after proximal enter-
ectomy, pancreatobiliary diversion or
colostomy closure is sufficient to promote
the development of neoplasia (Terpstra
et al., 1979; Williamson et al., 1978a,
1979b).
Unlike Nygaard (1967) we have found
no elongation of the remaining small
bowel after partial resection, though
initial measurements of the lenath of
bowel resected at operation were in-
evitably imprecise. The greater surface
area of the caecum after DSBR agrees
with our previous finding of luminal
dilatation in the shortened gut (William-
son et al., 1978a). Intestinal adaptation is
mostly achieved by i-nereased calibre and
mucosal thickness.
We thank Mr Peter Davies for statistical advice
and technical assistance and the Department of
Medical Illustration for supplying the figures. Tech-
nical help wa3 also given by the late Mr F. E.
Badrick and Mrs Barbara Butler. This work was
supported by a grant from the Cancer Researcli
Campaign, which we acknowledge with gratitude.
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